Featured News
AIM Blog
Recognizing AIM’s August Advocate of the Month: Vinitia Strong-McDonald
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Alzheimer’s Association Welcomes Announcement of CMS Coverage for FDA-approved Treatments
Association to Also Work with Other Payers, Health Systems to Deliver Broad Access Association Calls on CMS to Open Reconsideration...
Press Release
Alzheimer's Association Welcomes U.S. FDA Traditional Approval of Leqembi: Full Details
CHICAGO, July 6, 2023 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to grant traditional...
Press Release
Alzheimer's Association Welcomes U.S. FDA Traditional Approval of Leqembi
CHICAGO, July 6, 2023 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to grant traditional...
Press Release
Senate HELP Committee Advances Bipartisan Legislation to Renew Nation’s Commitment to Addressing the Alzheimer’s Crisis
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., June 15, 2023 — Today the Senate Committee on...
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...